Dr Mazareigos Featured in People
Congratulations to Dr George Mazareigos, MD, who was featured in People.com! Dr Mazareigos' expertise made a tremendous and lasting impact to a family in need of a transplant.
Congratulations to Dr George Mazareigos, MD, who was featured in People.com! Dr Mazareigos' expertise made a tremendous and lasting impact to a family in need of a transplant.
Congratulations to Drs Joseph Church, Hamza Yazdani, and Marcus Malek who have been awarded grants from the Competitive Medical Research Fund.
Link to original story is here.
Congratulations to Rakesh Sindhi, MD for contributing to the article, “Biliary atresia is associated with polygenic susceptibility in ciliogenesis and planar polarity effector genes” which was published in the Journal of Hepatology (journal impact factor: 30). The authors expand on their study regarding biliary atresia.
A new award for research to be conducted by Marcus M. Malek, MD, FAAP has been approved for funding.
Congratulations to Kevin Mollen, M.D., who has been appointed Associate Surgeon-in-Chief of Children’s Surgical Services. Dr. Mollen will begin his duties as Associate Surgeon-in-Chief on June 1, 2023, replacing the departing Dr. Barbara Gaines.
Congratulations to Heather Mentrup, PhD, who received notice from the National Institutes of Health that they will fund her F32 fellowship award, “Intestinal Stem Cell Metabolism in Inflammatory Bowel Disease Mucosal Healing.” The purpose of the F32 award program is to enhance the research training of promising postdoctoral candidates with the potential to become productive, independent investigators.
JRDF will fund the project “Investigating Combinatorial Use of Inhibitors of Focal Adhesion Kinase and PFKFB3 for Reversal of Type 1 Diabetes (T1D),” on which Jon D. Piganelli, PhD, is the principal investigator and Farzad Esni, PhD, is co-investigator. Here, the investigators aim to advance the pursuit of a treatment for T1D without undesirable side effects by testing a gene therapy approach in diabetic mice. Their ultimate goal is to progress towards clinical trials in humans with diabetes.
A new grant and a new sub-award for research to be conducted by Jon D. Piganelli, PhD, will receive funding.